<i>Kluyveromyces marxianus</i> and <i>Saccharomyces boulardii</i> induce distinct levels of dendritic cell cytokine secretion and significantly different T cell responses <i>In Vitro</i> by Smith, Ida Mosbech et al.
u n i ve r s i t y  o f  co pe n h ag e n  
Københavns Universitet
Kluyveromyces marxianus and Saccharomyces boulardii induce distinct levels of
dendritic cell cytokine secretion and significantly different T cell responses In Vitro
Smith, Ida Mosbech; Baker, Adam; Christensen, Jeffrey E; Boekhout, Teun; Frøkiær, Hanne;
Arneborg, Nils; Jespersen, Lene
Published in:
P L o S One
DOI:
10.1371/journal.pone.0167410
Publication date:
2016
Document version
Publisher's PDF, also known as Version of record
Citation for published version (APA):
Smith, I. M., Baker, A., Christensen, J. E., Boekhout, T., Frøkiær, H., Arneborg, N., & Jespersen, L. (2016).
Kluyveromyces marxianus and Saccharomyces boulardii induce distinct levels of dendritic cell cytokine secretion
and significantly different T cell responses In Vitro. P L o S One, 11(11), [e0167410].
https://doi.org/10.1371/journal.pone.0167410
Download date: 03. Feb. 2020
RESEARCH ARTICLE
Kluyveromyces marxianus and Saccharomyces
boulardii Induce Distinct Levels of Dendritic
Cell Cytokine Secretion and Significantly
Different T Cell Responses In Vitro
Ida M. Smith1,2¤*, Adam Baker1, Jeffrey E. Christensen3, Teun Boekhout4,
Hanne Frøkiær5, Nils Arneborg2, Lene Jespersen2
1 Health & Nutrition Division Discovery, Chr. Hansen A/S, Hørsholm, Denmark, 2 Department of Food
Science, University of Copenhagen, Frederiksberg, Denmark, 3 Institute of Metabolic and Cardiovascular
Disease, French Institute of Health and Medical Research (INSERM), Toulouse, France, 4 CBS-KNAW
Fungal Biodiversity Centre, Utrecht, The Netherlands, 5 Department of Veterinary Disease Biology,
University of Copenhagen, Frederiksberg, Denmark
¤ Current address: Biometrics Medical Writing, Global Clinical Development, ALK A/S, Hørsholm, Denmark
* ismdk@alk.net
Abstract
Interactions between members of the intestinal microbiota and the mucosal immune system
can significantly impact human health, and in this context, fungi and food-related yeasts are
known to influence intestinal inflammation through direct interactions with specialized
immune cells in vivo. The aim of the present study was to characterize the immune modulat-
ing properties of the food-related yeast Kluyveromyces marxianus in terms of adaptive
immune responses indicating inflammation versus tolerance and to explore the mechanisms
behind the observed responses. Benchmarking against a Saccharomyces boulardii strain
with probiotic effects documented in clinical trials, we evaluated the ability of K. marxianus
to modulate human dendritic cell (DC) function in vitro. Further, we assessed yeast induced
DC modulation of naive T cells toward effector responses dominated by secretion of IFNγ
and IL-17 versus induction of a Treg response characterized by robust IL-10 secretion. In
addition, we blocked relevant DC surface receptors and investigated the stimulating proper-
ties of β-glucan containing yeast cell wall extracts. K. marxianus and S. boulardii induced
distinct levels of DC cytokine secretion, primarily driven by Dectin-1 recognition of β-glucan
components in their cell walls. Upon co-incubation of yeast exposed DCs and naive T cells,
S. boulardii induced a potent IFNγ response indicating TH1 mobilization. In contrast, K.
marxianus induced a response dominated by Foxp3+ Treg cells, a characteristic that may
benefit human health in conditions characterized by excessive inflammation and positions
K. marxianus as a strong candidate for further development as a novel yeast probiotic.
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Introduction
Our gastrointestinal tract contains an overwhelming number of living microorganisms with
an increasingly recognized impact on human health[1]. The ability to effectively protect
against invading species while maintaining tolerance to commensals and avoiding destructive
inflammatory responses to harmless luminal substances is a key feature of the intestinal
immune system[2]. In this context, dendritic cells (DCs) present in the mucosal-associated
lymphoid tissues lining the human gut are central players involved in microbial sensing and
shaping of appropriate adaptive immune responses.
While most studies of microbiota composition have focused solely on the prokaryotic com-
ponent, communities of eukaryotic microorganisms are present in the mammalian gut[3], and
commensal fungi have been found to influence hosts’ susceptibility to colitis[4]. In addition,
food-related yeasts and live microorganisms administered as dietary supplements have the
potential to impact human health through interactions with intestinal immune cells. Specifi-
cally, Saccharomyces boulardii (taxonomically acknowledged as belonging to the S. cerevisiae
species[5] but in the following text referred to as S. boulardii) has shown a positive impact on
disease outcome in clinical studies of inflammatory bowel diseases such as Crohn’s disease and
ulcerative colitis[6], indicating an ability of S. boulardii to influence human immune responses
underlying intestinal inflammation. The non-Saccharomyces yeast species Kluyveromyces
marxianus comprises food-related yeasts typically isolated from fermented dairy products[7],
and the generally non-pathogenic nature of this species is reflected by the fact that K. marxia-
nus is included in the European Food Safety Authority list of approved microorganisms with
qualified presumption of safety (QPS) status[8]. Further, K. marxianus has been found to
engage human immune cells in vitro[9, 10] and is of interest as a potential candidate for devel-
opment of novel yeast probiotics.
DC recognition of microorganisms relies on a wide variety of pattern recognition receptors
(PRRs) expressed on the cell surface interacting with specific conserved microbial structures.
Yeast recognition is primarily dependent on toll-like receptor (TLR) 2, which recognizes the
yeast cell wall preparation zymosan[11, 12], and a number of PRRs known as C-type lectin
receptors recognizing specific components of the yeast cell wall[13]. Specifically, the outer
mannan layer is recognized by the mannose receptor as well as the DC-specific ICAM-3 grab-
bing non-integrin (DC-SIGN), while the underlying network of branched β-glucans is recog-
nized by Dectin-1[13–16]. Ligand binding initiates intracellular signaling events in DCs,
microbial uptake by phagocytosis, and DC maturation. This process involves modulation of
co-stimulatory molecules and changes in chemokine receptor expression as well as in cytokine
secretion, reflecting a DC phenotype ready for migration and antigen presentation to naive T
cells in draining lymph nodes.
Microbial recognition results in DC secretion of chemokines and cytokines with distinct
inflammatory effects. For example, DC secretion of IL-12 promotes expansion of the IFNγ
secreting TH1 cell subset, whereas DC secretion of IL-1β and IL-6 contributes to a response
dominated by the IL-17 secreting TH17 subpopulation[17]. Conversely, conditioning DCs
toward a predominantly IL-10 secreting phenotype promotes IL-10 secreting Foxp3+ regula-
tory T cells (Treg) contributing to intestinal tolerance[2, 18, 19]. In this context, microorgan-
isms with the ability to direct expansion of the Treg subset promote tolerance to the intestinal
microbiota and have been found to alleviate symptoms in several conditions characterized by
excessive inflammation[20–27].
Microbial cell wall components such as fungal β-glucans are known potentiators of
innate immunity, a property that has been explored for antitumor targeting[28–30]. In
addition, yeast β-glucans and Dectin-1 signaling have been implicated in protection from
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type 1 diabetes as well as experimentally induced colitis in rodent models[4, 31, 32], thus repre-
senting microbial modulation of host immune responses without administration of live
microorganisms.
The aim of the present study was to characterize the immune cell modulating properties of
K. marxianus in terms of adaptive immune responses indicating inflammation versus toler-
ance. Benchmarking against the established yeast probiotic S. boulardii, we evaluated the abil-
ity of K. marxianus to modulate human DC function in vitro. Further, we evaluated yeast
induced DC modulation of naive T cells toward effector responses dominated by IFNγ secret-
ing TH1 cells and IL-17 secreting TH17 cells versus induction of a Treg response characterized
by high levels of IL-10 secretion. In addition, we explored the mechanisms behind the
observed responses by blocking relevant DC surface receptors and investigating the immune
cell stimulating properties of β-glucan containing yeast cell wall extracts.
Materials and Methods
Yeast strains and growth conditions
Kluyveromyces marxianus CBS1553 was obtained from CBS-KNAW Fungal Biodiversity Cen-
tre (CBS), The Netherlands. S. boulardii (Ultra-Levure) was obtained from the dietary supple-
ment Ultra-Levure capsules, lot no 7930 (Biocodex, France). Strain identity was verified by
DNA sequencing of the D1/D2 domain (NL1/NL4 primers)[33]. Strains were cultured in YPD
media (0.5% yeast extract, 1% peptone, 1.1% D-glucose) at 30˚C under aerobic conditions.
Early stationary growth phase yeast cultures were harvested by centrifugation, washed twice
with DC media (RPMI 1640 supplemented with 10 mM HEPES (Sigma-Aldrich, Schnelldorf,
Germany) and 50 μM 2-ME (Sigma-Aldrich, Schnelldorf, Germany)), OD adjusted in DC
media containing 10% glycerol, and cryopreserved at -80˚C until time of DC stimulation.
Upon thawing at ambient temperature, viability of yeast cultures was verified by staining with
propidium iodide and enumeration of intact yeast cells by flow cytometry. In addition, the
cytokine inducing properties of cryopreserved yeast and fresh yeast preparations were com-
pared during the development of the experimental setup. Results showed that cryopreserved
and fresh yeast (including among others S. boulardii and K. marxianus) induced very similar
levels of DC cytokine secretion (IL-12, IL-10, IL-6, and IL-1β).
Preparation of yeast cell wall extracts
Cell wall extracts of K. marxianus CBS1553 and S. boulardii (Ultra-Levure) were prepared
according to de Groot et al. 2004[34]. Early stationary growth phase yeast cultures were har-
vested by centrifugation, washed with cold, sterile H2O and with 10 mM Tris-HCl, pH 7.5, and
resuspended in 10 mM Tris-HCl, pH 7.5 at 1×107 cells/μL. Yeast cells were disintegrated using
250–300 μm glass beads (Sigma-Aldrich, St. Louis, MO, USA) in the presence of a protease
inhibitor cocktail (Sigma-Aldrich, St. Louis, MO, USA). Yeast cell disintegration was per-
formed in small volumes (1 mL) by brief, vigorous shaking (30 Hz, 6 min) on a Retsch MM200
instrument (F. Kurt Retsch GmbH, Haan, Germany). To remove non-covalently linked pro-
teins and intracellular contaminants, isolated yeast cell walls were washed extensively with 1 M
NaCl and extracted twice for 5 min at 99˚C with a detergent solution (50 mM Tris-HCl, pH
7.8, containing 2% SDS, 100 mM Na-EDTA, and 40 mM 2-ME (all from Sigma-Aldrich,
St. Louis, MO, USA)). Finally, yeast cell wall extracts were washed three times with sterile
H2O, resuspended in sterile H2O, and stored at -20˚C until time of DC stimulation. Absence
of culturable yeast cells in the final yeast cell wall extracts was determined by colony counts
after 48 h incubation of YPD agar plates at 30˚C.
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Monocyte-derived DC generation
Immature monocyte-derived DCs were generated in vitro by a 6 day procedure as described
by Zeuthen et al. 2008[35]. Human buffy coats from healthy donors were supplied by Depart-
ment of Clinical Immunology at Copenhagen University Hospital, Copenhagen, Denmark.
Use of human samples with no identifying information was approved by The National Com-
mittee on Health Research and the Danish Society for Clinical Immunology, and all donors
gave informed written consent upon donation. Briefly, human PBMCs were obtained from
buffy coats by density gradient centrifugation using Ficoll-Paque PLUS (GE Healthcare, Frei-
burg, Germany). Monocytes were isolated by positive selection for CD14 using magnetic-acti-
vated cell sorting with CD14 microbeads (Miltenyi Biotec, Bergisch Gladbach, Germany) and
cultured at a density of 2 x 106 cells/mL in complete DC media (RPMI 1640 supplemented
with 10 mM HEPES (Sigma-Aldrich, Schnelldorf, Germany), 50 μM 2-ME (Sigma-Aldrich,
Schnelldorf, Germany), 2 mM L-glutamine (Life Technologies Ltd, Paisley, UK), 10% heat-
inactivated fetal bovine serum (Invitrogen, Paisley, UK), 100 U/mL penicillin (Biological
Industries, Kibbutz Beit-Haemek, Israel), and 100 μg/mL streptomycin (Biological Industries,
Kibbutz Beit-Haemek, Israel)) containing 30 ng/mL human recombinant IL-4 and 20 ng/mL
human recombinant GM-CSF (both from Sigma-Aldrich, Saint Louis, MO, USA) at 37˚C, 5%
CO2. Fresh complete DC media containing full doses of IL-4 and GM-CSF was added after
three days of culture. At day 6, differentiation to immature DCs was verified by surface marker
expression analysis (CD11c >90% expression; CD1a >75% expression).
DC stimulation
Immature DCs were resuspended in fresh complete DC media containing no antibiotics,
seeded in 96-well plates at 1 × 105 cells/well, and allowed to acclimate at 37˚C, 5% CO2, for at
least one hour before stimulation. DC stimulation using thawed yeast strains was performed at
a yeast:DC ratio of 10:1 (MOI 10). DC stimulation using thawed yeast cell wall extracts was
performed with extract material prepared from a number of yeast cells corresponding to a
yeast:DC ratio of 10:1 (MOI 10). Where indicated, DCs were pre-incubated for 30 min with
20 μM cytochalasin D derived from Zygosporium mansonii (Sigma-Aldrich, Saint Louis, MO,
USA), 1 μg/mL monoclonal blocking antibodies specific for human Dectin-1/CLEC7A (clone
259931), TLR2 (clone 383936), or DC-SIGN/CD209 (clone 120507), or a nonspecific isotype
matched control antibody (all from R&D Systems, Oxon, UK). Stimulated DCs were incubated
for 20 h at 37˚C, 5% CO2, as time-course experiments had shown a 20 h stimulation time to
result in quantifiable levels of all cytokines of interest. After 20 h stimulation, DCs were stained
for flow cytometric analysis of surface molecule expression or transferred to a 96-well plate for
naive T cell co-incubation, and DC supernatants were sterile filtered through a 0.2 μm Acro-
Prep Advance 96-well filter plate (Pall Corporation, Ann Arbor, MI, USA) and stored at -80˚C
until time of cytokine quantification.
DC co-incubation with autologous naive T cells
Autologous, naive CD45RA+CD45RO- T cells were isolated from human PBMCs by negative
selection using the Naive CD4+ T Cell Isolation Kit II (Miltenyi Biotec, Lund, Sweden) and
resuspended in fresh complete DC media at a density of 2 × 105 cells/mL. Co-incubation of
yeast stimulated DCs (i.e. DCs that had been pre-exposed to yeast as described under ’DC
stimulation’) and autologous, naive T cells was performed in 96-well plates at a DC:T cell ratio
of 1:20 by combining 2 × 104 DCs with 4 × 105 naive T cells, followed by incubation at 37˚C,
5% CO2 for 3 days. This co-incubation time was chosen based on time-course data showing
equivalent levels of cytokine secretion following co-incubation for 3, 5, and 7 days (data not
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shown). Where indicated, yeast stimulated DCs were pre-incubated for 30 min with 10 μg/mL
monoclonal neutralization antibodies specific for human IL-12p40/p70 (clone C8.6) (BD Bio-
sciences, Temse, Belgium) or TGFβ (clone 1D11) (R&D Systems, Oxon, UK), or appropriate
nonspecific isotype matched control antibodies. After 3 days co-incubation, cells were stained
for flow cytometric analysis of Treg subset expansion and cell culture supernatants were sterile
filtered through a 0.2 μm AcroPrep Advance 96-well filter plate (Pall Corporation, Ann Arbor,
MI, USA) and stored at -80˚C until time of cytokine quantification.
DC staining for expression of co-stimulatory molecules and chemokine
receptors
Immediately following 20 h stimulation time, DCs were collected, centrifuged at 200 × g for 5
min, and resuspended in cold PBS containing 2% BSA. Staining was performed using the fol-
lowing monoclonal antibodies: FITC-conjugated anti-CD80 (clone L307.4), FITC-conjugated
anti-CD86 (clone 2331), APC-conjugated anti-CCR6 (clone 11A9), FITC-conjugated anti-
CCR7 (clone 150503), and appropriate nonspecific isotype matched controls (all from BD Bio-
sciences, Erembodegem, Belgium). DCs were incubated with 1 μg/mL monoclonal antibodies
for 30 min on ice protected from light, followed by repeated wash steps using 1 mL cold PBS
2% BSA. Finally, DCs were resuspended in PBS 2% BSA and kept on ice until flow cytometric
analysis. Samples were acquired on an LSRFortessa flow cytometer (BD Biosciences, San Jose,
CA, USA) using FACSDiva software (BD Biosciences, San Jose, CA, USA).
T cell staining for quantification of Treg subset
Following 3 days co-incubation of yeast stimulated DCs and naive T cells, cells were washed
using cold CellWash (BD Biosciences, Erembodegem, Belgium) and resuspended in cold Stain
Buffer (BD Biosciences, Erembodegem, Belgium). For surface staining, cells were incubated
with PE-Cy7-conjugated anti-CD4 (clone SK3) and PerCP-Cy5.5-conjugated anti-CD25
(clone M-A251) or appropriate nonspecific isotype matched controls (all from BD Biosciences,
Erembodegem, Belgium) for 30 min on ice protected from light. For intracellular staining, sur-
face-stained cells were fixed and permeabilized using Human Foxp3 Buffer Set (BD Biosci-
ences, Erembodegem, Belgium), incubated with PE-conjugated anti-Foxp3 (clone 259D/C7)
or an appropriate nonspecific isotype matched control (both from BD Biosciences, Erembode-
gem, Belgium), and washed twice before analysis. Stained cells were acquired on an LSRFor-
tessa flow cytometer (BD Biosciences, San Jose, CA, USA) using FACSDiva software (BD
Biosciences, San Jose, CA, USA). Specific gates and quadrants were defined based on back-
ground staining of isotype controls. At least 10,000 cells were analyzed for each sample.
Cytokine quantification
Secreted levels of IL-12p70, IL-1β, IL-6, IL-10, IFNγ, and IL-17 were quantified by Cytometric
Bead Array Flex Sets (BD Biosciences, Erembodegem, Belgium) according to the manufactur-
er’s instructions. Briefly, fluorescent beads coated with monoclonal capture antibodies were
mixed with PE-conjugated detection antibodies and recombinant standards or test samples
and allowed to form sandwich complexes during subsequent incubations protected from light.
After repeated wash steps, samples were acquired on an LSRFortessa flow cytometer (BD Bio-
sciences, San Jose, CA, USA) and data analysis was performed using the FCAP Array 3 soft-
ware (BD Biosciences, San Jose, CA, USA). Detection limits for individual cytokines were as
follows: 0.6 pg/mL IL-12, 2.3 pg/mL IL-1β, 1.6 pg/mL IL-6, 0.13 pg/mL IL-10, 1.8 pg/mL IFNγ,
and 0.3 pg/mL IL-17.
Regulatory Immune Response Induced by K. marxianus
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Statistical analysis
Data are expressed as mean ± SEM. Statistical analyses, including one-way and two-way
ANOVA with Tukey’s test for multiple comparisons, were performed using GraphPad Prism 6
(GraphPad Software, La Jolla, USA). Statistically significant results are indicated in figures as
follows: , P<0.05; , P<0.01; , P<0.001; ns, not significant.
Results
K. marxianus and S. boulardii induce distinct patterns of human DC
cytokine secretion and maturation
Based on the fact that commensal fungi and food-related yeasts are known to influence intesti-
nal inflammation through direct interactions with specialized immune cells in vivo, we evalu-
ated the ability of K. marxianus to modulate the function of human DCs in vitro. As a point of
reference, we included a S. boulardii strain with probiotic effects documented in clinical trials
[6]. Human monocyte-derived DCs were exposed to each yeast strain at a 10:1 yeast:DC ratio
(MOI 10) and yeast induced responses were evaluated after 20 h stimulation, as time-course
experiments had shown a 20 h stimulation time to result in quantifiable levels of all cytokines
of interest (data not shown). As expected, S. boulardii engaged human DCs and induced robust
secretion of IL-12, IL-1β, IL-6, and IL-10 (Fig 1A). Similarly, K. marxianus induced statistically
significant DC secretion of all four cytokines, confirming previous results[10]. While the levels
of DC IL-12 and IL-1β secretion appeared to be significantly stronger in response to stimula-
tion with K. marxianus compared to S. boulardii, the two yeasts induced similar levels of IL-6
and IL-10 secretion in DCs. In addition, both yeasts induced DC maturation, as assessed by
expression levels of co-stimulatory molecules and chemokine receptors (Fig 1B). Specifically,
S. boulardii induced elevated levels of CD80 as well as CD86 expression, and K. marxianus
induced elevated levels of CD86 expression. Further, both yeasts induced significant down-
Fig 1. K. marxianus and S. boulardii induce distinct DC modulation. A. Levels of IL-12, IL-1β, IL-6, and IL-10 secreted by human monocyte-derived DCs
following 20 h incubation with DC media (unstimulated), a probiotic reference strain (S. boulardii), or K. marxianus at a yeast:DC ratio of 10:1 (MOI 10). Data
are representative of at least five independent experiments, error bars represent SEM. B. Levels of DC expression of CD80, CD86, CCR6, and CCR7
following 20 h incubation with DC media (unstimulated), a probiotic reference strain (S. boulardii), or K. marxianus at a yeast:DC ratio of 10:1 (MOI 10). Data
are expressed as mean ± SEM of at least five independent experiments (five donors). One-way ANOVA, Tukey’s multiple comparisons test, indicating
significant differences as follows: *, P<0.05; **, P<0.01; ***, P<0.001; ns, not significant.
doi:10.1371/journal.pone.0167410.g001
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regulation of CCR6 and up-regulation of CCR7, indicative of activation of immature DCs to a
mature phenotype primed for lymph node migration and efficient antigen presentation.
K. marxianus induces a strong Treg cell response whereas S. boulardii
induces a T cell response comprised of IFNγ, IL-17, and IL-10
Given that a key mechanism behind microbial modulation of excessive intestinal inflamma-
tion involves induction of immune responses driven by Treg cells, we evaluated the ability of K.
marxianus or S. boulardii to induce DC modulation of T cell function in vitro. We co-incu-
bated yeast exposed DCs with autologous, naive T cells for 3 days, after which secreted levels of
IFNγ, IL-17, and IL-10 were quantified. This co-incubation time was chosen based on time-
course data showing equivalent levels of cytokine secretion following co-incubation for 3, 5,
and 7 days (data not shown). As presented in Fig 2A, DCs exposed to the probiotic reference
strain S. boulardii induced high levels of T cell IFNγ secretion, low but detectable IL-17 secre-
tion, and robust IL-10 secretion, suggesting a S. boulardii induced T cell response composed of
IFNγ secreting TH1 cells, IL-17 secreting TH17 cells, as well as IL-10 secreting Treg cells. In con-
trast, despite secreting robust levels of IL-12 (Fig 1A), DCs exposed to K. marxianus induced
no detectable T cell secretion of IFNγ or IL-17, but robust IL-10 secretion (Fig 2A), indicating
a K. marxianus induced T cell response dominated by IL-10 secreting Treg cells. In control
wells containing yeast cells and naive T cells, but no DCs, we observed no cytokine secretion
(Fig 2A), indicating that any detected cytokine secretion resulted from interactions between
Fig 2. K. marxianus induces a strong Treg cell response whereas S. boulardii induces a T cell response comprised of IFNγ, IL-
17, and IL-10. T cell responses following 3 days co-incubation of yeast stimulated DCs and naive autologous T cells. For each yeast, DC
stimulation was performed at a yeast:DC ratio of 10:1 (MOI 10), and the subsequent co-incubation of DCs and naive T cells was
performed at a DC:T cell ratio of 1:20. A. T cell secretion levels of IFNγ, IL-17, and IL-10. Data are representative of at least five
independent experiments, error bars represent SEM. B. Quantification of the Treg subset as CD4+CD25+Foxp3+ cells. Dotplots gated on
the CD4+ cell population from a single representative donor displaying the percentage of cells in each quadrant. C. Data from three
independent experiments (three donors) expressed as the percentage of CD25+Foxp3+ cells in the CD4+ cell population, error bars
represent SEM. One-way ANOVA, Tukey’s multiple comparisons test, indicating significant differences as follows: *, P<0.05; **,
P<0.01; ***, P<0.001; ns, not significant.
doi:10.1371/journal.pone.0167410.g002
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yeast stimulated DCs and naive T cells rather than direct yeast stimulation of T cells. Quantifi-
cation of the Treg subset by cellular immunostaining for CD4, CD25, and Foxp3 following 3
days co-incubation with yeast exposed DCs supported the cytokine data (Fig 2B and 2C).
Whereas DCs exposed to S. boulardii induced elevated numbers of CD25+Foxp3+ cells com-
pared to unstimulated cells, K. marxianus exposed DCs induced higher numbers of Foxp3+
cells and a greater expansion of the proportion of CD25+Foxp3+ cells.
Yeast induced DC stimulation involves Dectin-1
Using monoclonal blocking antibodies against the PRRs Dectin-1, TLR2, and DC-SIGN, we
evaluated PRR involvement in yeast induced DC cytokine secretion. As displayed in Fig 3A,
specific blockade of the β-glucan receptor Dectin-1 resulted in significantly lower levels of K.
marxianus or S. boulardii induced DC cytokine secretion across all cytokines measured. In
contrast, blocking TLR2 or DC-SIGN had no impact on yeast induced cytokine secretion.
As Dectin-1 is involved in initiating phagocytosis in myeloid phagocytes, we investigated
the importance of yeast uptake for the observed yeast induced DC cytokine secretion.
Obstructing phagocytosis through DC pretreatment with the specific inhibitor of actin poly-
merization cytochalasin D[36], we observed dramatic and opposing effects on yeast induced
DC cytokine secretion (Fig 3B). Whereas DC pretreatment with cytochalasin D prevented
yeast induced IL-12 secretion and K. marxianus induced IL-6 secretion, the opposite was true
for yeast induced IL-1β and IL-10 secretion. Cytochalasin D pretreatment resulted in 10-fold
higher levels of yeast induced IL-1β secretion and a clear upward trend in levels of yeast
induced IL-10 secretion.
Fig 3. Yeast induced DC cytokine secretion relies on Dectin-1 mediated phagocytosis. DC secretion levels of IL-12, IL-1β, IL-6, and IL-10 following 20 h
stimulation with DC media (unstimulated), a probiotic reference strain (S. boulardii), or K. marxianus at a yeast:DC ratio of 10:1 (MOI 10). A. For each yeast
strain, DC stimulation was performed following a 30 min DC pre-incubation with HBSS (no treatment), a nonspecific isotype matched control antibody (control
mAb) or monoclonal blocking antibodies specific for Dectin-1, TLR2, or DC-SIGN. Data are expressed as percent cytokine secretion relative to pre-incubation
with HBSS (no treatment) and displayed as mean ± SEM of four independent experiments (four donors). B. For each yeast strain, DC stimulation was
performed following a 30 min DC pre-incubation with HBSS (no treatment) or 20μM Cytochalasin D, a potent inhibitor of actin polymerization. Data are
expressed as percent cytokine secretion relative to pre-incubation with HBSS (no treatment) and displayed as mean ± SEM of three independent experiments
(three donors). Two-way ANOVA, Tukey’s multiple comparisons test. *, P<0.05; **, P<0.01; ***, P<0.001.
doi:10.1371/journal.pone.0167410.g003
Regulatory Immune Response Induced by K. marxianus
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Beta-glucan containing yeast cell wall extracts are potent inducers of IL-
1β, IL-6, and IL-10 but fail to induce IL-12
Based on the observation that Dectin-1, which recognizes fungal β-glucans, appeared to medi-
ate yeast recognition in our experimental setup, we prepared β-glucan containing yeast cell
wall extracts of K. marxianus and S. boulardii and explored their cytokine inducing properties
in human monocyte-derived DCs (Fig 4). Strikingly, cell wall extracts prepared from either
yeast strain induced DC secretion of IL-1β, IL-6, and IL-10 at levels significantly higher than
observed with intact yeast cells. In contrast, none of the yeast cell wall extracts induced detect-
able levels of IL-12 secretion in DCs. As presented in Fig 5A, Dectin-1 blockade reduced the
levels of DC IL-10 secretion induced by either yeast cell wall extract by approximately 40%,
while DC IL-1β secretion levels appeared slightly elevated (by approximately 35%). Yeast cell
wall extract induced DC IL-6 secretion appeared unaffected by Dectin-1 blockade, and in addi-
tion, blocking TLR2 or DC-SIGN had no significant effect on DC cytokine secretion induced
by either cell wall extract (Fig 5A).
When investigating the importance of DC phagocytosis for yeast cell wall extract induced
DC cytokine secretion, we found that blocking uptake through pretreatment with cytochalasin
D completely obstructed cell wall extract induced DC cytokine secretion (Fig 5B). This con-
trasts with the observation that viable K. marxianus and S. boulardii were capable of inducing
IL-1β and IL-10 secretion in DCs independently of phagocytic internalization (Fig 3B).
Discussion
Although the number of fungal species is lower than the number of prokaryotic species present
in the human gastrointestinal tract, the mycobiome rivals the microbiome in terms of biomass,
indicating that fungi may play a bigger role in microbial communities than would be suspected
Fig 4. β-glucan containing yeast cell wall extracts are poor IL-12 inducers but potent inducers of DC IL-1β, IL-6, and IL-10 secretion. A. DC
secretion levels of IL-12, IL-1β, IL-6, and IL-10 following 20 h stimulation with live S. boulardii or S. boulardii cell wall extract corresponding to a yeast:DC ratio
of 10:1 (MOI 10). B. DC secretion levels of IL-12, IL-1β, IL-6, and IL-10 following 20 h stimulation with live K. marxianus or K. marxianus cell wall extract
corresponding to a yeast:DC ratio of 10:1 (MOI 10). Data are representative of three independent experiments, error bars represent SEM. One-way ANOVA,
Tukey’s multiple comparisons test. *, P<0.05; **, P<0.01; ***, P<0.001.
doi:10.1371/journal.pone.0167410.g004
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from species numbers alone. In this context, commensal fungi and food-derived yeasts are
known to interact with specialized immune cells present in the tissues lining the human gut.
In the present study, a S. boulardii strain with probiotic effects documented in clinical trials[6]
was found to modulate the function of human immune cells in vitro. This corresponds well
with several studies by us and others reporting S. boulardii induced modulation of immune
cell function in vitro[10, 37–39] and reduced inflammatory scores in experimental colitis mod-
els in rodents[32, 40–47]. Collectively, these findings indicate that S. boulardii administration
has a beneficial impact on immune responses underlying intestinal inflammation. For the
non-Saccharomyces yeast K. marxianus, typically isolated from fermented dairy products
known for their health-promoting effects, we also observed modulation of human DC function
in vitro. K. marxianus induced robust DC cytokine secretion across all cytokines measured,
and this observed ability to modulate cytokine secretion of specialized immune cells agrees
well with published reports[9, 10]. In addition, K. marxianus induced elevated expression lev-
els of the co-stimulatory molecule CD86 but not CD80, and K. marxianus modulated DC che-
mokine receptor expression to levels near-identical to those induced by S. boulardii. We
cannot exclude that the differential expression of CD80 and CD86 after stimulation with these
two yeasts determines the resulting distinct T cell responses, as it has previously been reported
that the relative effect of CD80 and CD86 influences TH polarization and that CD80 blockade
downregulates the TH1 response[48]. In addition, while CD80 and CD86 have been reported
to play distinct functional roles in animal models of autoimmune disease, their individual con-
tributions to shaping downstream T cell responses remain incompletely understood[49].
Fig 5. Yeast cell wall extract induced cytokine secretion involves multiple PRRs and is entirely dependent on DC uptake. DC secretion levels of IL-
12, IL-1β, IL-6, and IL-10 following 20 h stimulation with DC media (unstimulated) or yeast cell wall extracts prepared from a probiotic reference strain (S.
boulardii) or K. marxianus corresponding to a yeast:DC ratio of 10:1 (MOI 10). A. DC stimulation was performed following a 30 min DC pre-incubation with
HBSS (no treatment), a nonspecific isotype matched control antibody (control mAb) or monoclonal blocking antibodies specific for Dectin-1, TLR2, or
DC-SIGN. Data are expressed as percent cytokine secretion relative to pre-incubation with HBSS (no treatment) and displayed as mean ± SEM of two
independent experiments. Two-way ANOVA, Dunnett’s multiple comparisons test. *, P<0.05; **, P<0.01; ***, P<0.001. ND, not detected. B. DC stimulation
was performed following a 30 min DC pre-incubation with HBSS (no treatment) or 20μM Cytochalasin D, a potent inhibitor of actin polymerization. Data are
expressed as percent cytokine secretion relative to pre-incubation with HBSS (no treatment) and displayed as mean ± SEM of two independent experiments.
Two-way ANOVA, Tukey’s multiple comparisons test. *, P<0.05; **, P<0.01; ***, P<0.001. ND, not detected.
doi:10.1371/journal.pone.0167410.g005
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Collectively, these data demonstrate K. marxianus induced maturation of human DCs indi-
cating functional similarities between K. marxianus and S. boulardii.
Subsequent co-incubation of yeast stimulated DCs and naive T cells revealed distinct T cell
responses induced by the two yeasts. Whereas the established probiotic yeast S. boulardii
induced a complex response involving IFNγ secreting TH1 cells as well as robust IL-10 secre-
tion and increased numbers of Foxp3+ Treg cells, K. marxianus induced a response dominated
by IL-10 secretion and Foxp3+ Treg cells. As numerous studies have linked microbial induction
of Foxp3+ Treg responses to beneficial effects in conditions characterized by excessive intestinal
inflammation[20, 23–27, 50–52], this observation suggests that K. marxianus induced Treg
responses may contribute to mucosal tolerance in vivo.
Dectin-1 has emerged as a central PRR relating innate fungal recognition to human health,
as observed by the fact that Dectin-1 deficiency results in an elevated susceptibility to colitis
[4]. We identified Dectin-1 as key for DC recognition of K. marxianus as well as S. boulardii in
our experimental setup, indicating that recognition relies on conserved β-glucans present in
cell walls of yeasts representing phylogenetically distinct genera. This agrees well with a study
on DC recognition and uptake of yeasts representing the Saccharomyces, Kluyveromyces,
Pichia, and Schizosaccharomyces genera, in which Dectin-1 blockade resulted in significantly
lower levels of phagocytic internalization of yeasts[53]. In contrast to reports of TLR2 involve-
ment in DC recognition of the S. cerevisiae derived cell wall preparation zymosan[11], TLR2
blockade had no effect on yeast induced DC cytokine secretion in the present study. Similarly,
the PRR DC-SIGN, which binds mannose- or fucose-containing carbohydrates in microbial
cell walls, did not appear involved in DC recognition of K. marxianus or S. boulardii in our
experimental setup. However, since Dectin-1 blockade did not entirely prevent yeast induced
DC cytokine secretion (reduction to<50% of unobstructed conditions), additional PRRs are
likely to contribute to yeast recognition. Whereas several studies have shown the mannose
receptor to be involved in DC internalization of pathogenic yeasts such as Candida albicans
and Cryptococcus neoformans[54, 55], a more recent study showed no modulation of C. albi-
cans induced cytokine secretion by human PBMCs in the presence of a specific mannose
receptor inhibitor[56].
In addition to induction of downstream signaling pathways leading to modulation of DC
cytokine secretion, yeast recognition by Dectin-1 initiates phagocytic uptake[57]. In the pres-
ent study, interfering with DC phagocytosis through cytochalasin D pretreatment had a signif-
icant impact on yeast induced DC cytokine secretion. K. marxianus induced DC IL-12 and IL-
6 secretion were obstructed by cytochalasin D, indicating a mechanism dependent on phago-
cytic internalization of K. marxianus. In contrast, the significant increase in DC IL-1β secre-
tion induced by K. marxianus or S. boulardii in the presence of cytochalasin D indicates a
mechanism operating independently of yeast uptake. While the observed effects of cytochala-
sin D pretreatment appear to reflect inhibition of phagocytic uptake of the yeasts, this may be
more conclusively proven by including a non-particulate stimulus in the experimental setup,
something that was not part of the present study.
Interestingly, Dectin-1 mediated activation of a noncanonical caspase-8 inflammasome
capable of both induction and maturation of IL-1β independently of microbial internalization
was described recently[58], a finding that may support our observation of yeast induced DC
IL-1β secretion in the absence of phagocytic uptake. Specifically, C. albicans was found to
induce induction and maturation of IL-1β in human DCs through a mechanism dependent
upon Dectin-1, ASC, and caspase-8 but independently of NLPR3, caspase-1, and phagocytosis
[58]. However, alternative IL-1β processing via caspase-8 was not experimentally confirmed in
the present study.
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In the context of immune modulating properties of yeasts, it is well established that fungal
β-glucans have immune potentiating effects[28, 29]. In the present study, DC stimulation with
β-glucan containing yeast cell wall extracts prepared from K. marxianus or S. boulardii elicited
significantly higher secretion levels of IL-1β, IL-6, and IL-10 as compared to stimulation with
intact yeast cells. As β-glucan masking by outer cell wall layers of mannan or α-glucans is an
established immune evasion strategy employed by fungal pathogens[59–61], and as the yeast
cell wall extract preparation procedure performed in the present study was designed for β-glu-
can extraction, demasking of β-glucans is likely a contributing factor in the observed immune
potentiation compared to intact yeast cells. Whereas live K. marxianus did not induce signifi-
cant levels of T cell IL-17 secretion, on the basis of the data presented in this study, it cannot
be excluded that the significantly elevated levels of DC secretion of IL-1β and IL-6 induced by
stimulation with K. marxianus cell wall extract may result in T cell IL-17 secretion. Future
studies are needed to clarify this.
Strikingly, cell wall extracts prepared from K. marxianus or S. boulardii failed to induce
detectable levels of DC IL-12 secretion in the present study. This mirrors findings from a study
comparing cytokine inducing properties of β-glucans from numerous sources, in which yeast-
derived β-glucans induced IL-6 and IL-10 but no detectable IL-12[62]. A similar discrepancy
between IL-12 inducing properties of intact cells and isolated cell wall components has been
reported for DC stimulation with lactobacilli[35]. Thus, as synergistic signaling involving mul-
tiple PRRs may be required for certain cytokine responses[63], the lack of detectable DC IL-12
secretion induced by yeast cell wall extracts in our experimental setup may indicate that Dec-
tin-1 signaling alone is insufficient for generation of an IL-12 response. In the present study,
IL-12 secretion induced by intact K. marxianus or S. boulardii cells was primarily dependent
on Dectin-1 and entirely uptake-dependent. Collectively, our observations support a mecha-
nism for IL-12 induction based on Dectin-1 mediated DC uptake of intact yeast cells, PRR
clustering at the phagocytic synapse, and a necessity for additional PRR signaling resulting in
DC secretion of IL-12.
In the present study, the immune modulating properties of K. marxianus were character-
ized alongside S. boulardii in an effort to evaluate whether K. marxianus expresses properties
consistent with probiotic functionality. Importantly, in order to truly assess the suitability of
K. marxianus as a probiotic yeast, further studies will need to include comparative testing
against a pathogenic species such as C. albicans. In conclusion, the present study demonstrates
distinct levels of DC cytokine secretion and significant differences in T cell responses induced
by K. marxianus and S. boulardii. For both yeasts, the observed interactions with human DCs
appeared to be primarily driven by Dectin-1 recognition of β-glucan components in their cell
walls. Specifically, β-glucan containing yeast cell wall extracts induced potent DC secretion of
IL-1β, IL-6, and IL-10, whereas IL-12 induction relied on Dectin-1 mediated uptake of intact
yeast cells, indicating the involvement of multiple PRRs. Upon co-incubation of yeast exposed
DCs and naive T cells, S. boulardii induced a potent IFNγ response indicating TH1 mobiliza-
tion. In contrast, K. marxianus induced a response dominated by Foxp3+ Treg cells, a charac-
teristic that may benefit human health in conditions characterized by excessive inflammation
and positions K. marxianus as a strong candidate for further development as a novel yeast
probiotic.
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